{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:45:43Z","timestamp":1792370743297,"version":"4.4.0"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dysfunctional glial cells play a pre-eminent role in schizophrenia pathophysiology. Post-mortem studies have provided evidence for significantly decreased glial cell numbers in different brain regions of individuals with schizophrenia. Reduced glial cell numbers are most pronounced in oligodendroglia, but reduced astrocyte cell densities have also been reported. This review highlights that oligo- and astroglial deficits are a key histopathological feature in schizophrenia, distinct from typical changes seen in neurodegenerative disorders. Significant deficits of oligodendrocytes in schizophrenia may arise in two ways: (i) demise of mature functionally compromised oligodendrocytes; and (ii) lack of mature oligodendrocytes due to failed maturation of progenitor cells. We also analyse in detail the controversy regarding deficits of astrocytes. Regardless of their origin, glial cell deficits have several pathophysiological consequences. Among these, myelination deficits due to a reduced number of oligodendrocytes may be the most important factor, resulting in the disconnectivity between neurons and different brain regions observed in schizophrenia. When glial cells die, it appears to be\u00a0through degeneration, a process which is basically reversible. Thus, therapeutic interventions that (i)\u00a0help rescue glial cells (ii)\u00a0or improve their maturation\u00a0might be a viable option. Since antipsychotic treatment alone does not seem to prevent glial cell loss\u00a0or maturation deficits, there is intense search for new therapeutic options. Current proposals range from the application of antidepressants and other chemical agents as well as physical exercise to engrafting healthy glial cells into brains of schizophrenia patients.<\/jats:p>","DOI":"10.1038\/s41380-024-02861-6","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T13:51:43Z","timestamp":1733406703000},"page":"1102-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration"],"prefix":"10.1038","volume":"30","author":[{"given":"Hans-Gert","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Nussbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Vasilevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-6503","authenticated-orcid":false,"given":"Thomas","family":"Nickl-Jockschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2611-2268","authenticated-orcid":false,"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2861_CR1","unstructured":"World Health Organization. Mental disorders. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders. Accessed 29 Jun 2024."},{"key":"2861_CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.schres.2022.03.004","volume":"243","author":"WS Stone","year":"2022","unstructured":"Stone WS, Phillips MR, Yang LH, Kegeles LS, Susser ES, Lieberman JA. Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia Res. 2022;243:154\u201362.","journal-title":"Schizophrenia Res"},{"key":"2861_CR3","doi-asserted-by":"crossref","unstructured":"Wawrzczak-Bargie\u0142a A, Bilecki W, Ma\u0107kowiak M. Epigenetic Targets in Schizophrenia Development and Therapy. Brain Sci. 2023;13:426.","DOI":"10.3390\/brainsci13030426"},{"key":"2861_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR. Rethinking schizophrenia. Nature. 2010;468:187\u201393.","journal-title":"Nature"},{"key":"2861_CR5","doi-asserted-by":"crossref","unstructured":"Peedicayil J. Genome-Environment Interactions and Psychiatric Disorders. Biomedicines. 2023;11:1209.","DOI":"10.3390\/biomedicines11041209"},{"key":"2861_CR6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archpsyc.1990.01810230039007","volume":"47","author":"B Pakkenberg","year":"1990","unstructured":"Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen psychiatry. 1990;47:1023\u20138.","journal-title":"Arch Gen psychiatry"},{"key":"2861_CR7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","volume":"67","author":"NA Uranova","year":"2004","unstructured":"Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Res. 2004;67:269\u201375.","journal-title":"Schizophrenia Res"},{"key":"2861_CR8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","volume":"161","author":"H-G Bernstein","year":"2015","unstructured":"Bernstein H-G, Steiner J, Guest PC, Dobrowolny H, Bogerts B. Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophrenia Res. 2015;161:4\u201318.","journal-title":"Schizophrenia Res"},{"key":"2861_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","volume":"7","author":"AG Dietz","year":"2020","unstructured":"Dietz AG, Goldman SA, Nedergaard M. Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry. 2020;7:272\u201381.","journal-title":"Lancet Psychiatry"},{"key":"2861_CR10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s12035-021-02672-8","volume":"59","author":"S-H Liu","year":"2022","unstructured":"Liu S-H, Du Y, Chen L, Cheng Y. Glial Cell Abnormalities in Major Psychiatric Diseases: A Systematic Review of Postmortem Brain Studies. Mol Neurobiol. 2022;59:1665\u201392.","journal-title":"Mol Neurobiol"},{"key":"2861_CR11","doi-asserted-by":"crossref","unstructured":"Jenkins AK, Ketchesin KD, Becker-Krail DD, McClung CA. Molecular Rhythmicity in Glia: Importance for Brain Health and Relevance to Psychiatric Disease. Biological Psychiatry. 2024;96:909\u201318.","DOI":"10.1016\/j.biopsych.2024.05.007"},{"key":"2861_CR12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrn2513","volume":"9","author":"T Paus","year":"2008","unstructured":"Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 2008;9:947\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"2861_CR13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/457675a","volume":"457","author":"NJ Allen","year":"2009","unstructured":"Allen NJ, Barres BA. Neuroscience: Glia - more than just brain glue. Nature. 2009;457:675\u20137.","journal-title":"Nature"},{"key":"2861_CR14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691\u2013705.","journal-title":"Neuron"},{"key":"2861_CR15","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA. 1994;91:10625\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2861_CR16","doi-asserted-by":"crossref","unstructured":"Li Q. Astrocytes: The Rising Stars that Regulate Synaptic Plasticity and Long-Term Memory Formation. In Synaptic tagging and capture: from synapses to behaviour. Springer International PU; 2024, pp. Springer, Cham (Switzerland) 309\u201320.","DOI":"10.1007\/978-3-031-54864-2_16"},{"key":"2861_CR17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1305087","volume":"15","author":"C Pallar\u00e9s-Moratalla","year":"2024","unstructured":"Pallar\u00e9s-Moratalla C, Bergers G. The ins and outs of microglial cells in brain health and disease. Front Immunol. 2024;15:1305087.","journal-title":"Front Immunol"},{"key":"2861_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0920-9964(02)00339-0","volume":"57","author":"G Rajkowska","year":"2002","unstructured":"Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophrenia Res. 2002;57:127\u201338.","journal-title":"Schizophrenia Res"},{"key":"2861_CR19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-008-0430-y","volume":"117","author":"A Schmitt","year":"2009","unstructured":"Schmitt A, Steyskal C, Bernstein H-G, Schneider-Axmann T, Parlapani E, Schaeffer EL, et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta neuropathologica. 2009;117:395\u2013407.","journal-title":"Acta neuropathologica"},{"key":"2861_CR20","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/schbul\/sbv157","volume":"42","author":"P Falkai","year":"2016","unstructured":"Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein H-G, Steiner J, et al. Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study. Schizophr Bull. 2016;42:S4\u201312.","journal-title":"Schizophr Bull"},{"key":"2861_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-019-01067-0","volume":"270","author":"P Falkai","year":"2020","unstructured":"Falkai P, Raabe F, Bogerts B, Schneider-Axmann T, Malchow B, Tatsch L, et al. Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a postmortem analysis. Eur Arch Psychiatry Clin Neurosci. 2020;270:413\u201324.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR22","doi-asserted-by":"crossref","unstructured":"Schmitt A, Tatsch L, Vollhardt A, Schneider-Axmann T, Raabe FJ, Roell L et al. Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study. Cells. 2022;11:3242.","DOI":"10.3390\/cells11203242"},{"key":"2861_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.17116\/jnevro2023123011103","volume":"123","author":"NS Kolomeets","year":"2023","unstructured":"Kolomeets NS, Uranova NA. Snizhenie chislennoi plotnosti oligodendrotsitov i klasterov oligodendrotsitov v golovke khvostatogo yadra pri shizofrenii. Zh nevrologii i psikhiatrii Im S S Korsakova. 2023;123:103\u201310.","journal-title":"Zh nevrologii i psikhiatrii Im S S Korsakova"},{"key":"2861_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.schres.2008.04.032","volume":"103","author":"AE Steffek","year":"2008","unstructured":"Steffek AE, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophrenia Res. 2008;103:71\u201382.","journal-title":"Schizophrenia Res"},{"key":"2861_CR25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.schres.2013.04.013","volume":"147","author":"MR Williams","year":"2013","unstructured":"Williams MR, Harb H, Pearce RKB, Hirsch SR, Maier M. Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depression. Schizophrenia Res. 2013;147:402\u20133.","journal-title":"Schizophrenia Res"},{"key":"2861_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00406-012-0328-5","volume":"263","author":"MR Williams","year":"2013","unstructured":"Williams MR, Hampton T, Pearce RKB, Hirsch SR, Ansorge O, Thom M, et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2013;263:41\u201352.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00406-013-0479-z","volume":"264","author":"MR Williams","year":"2014","unstructured":"Williams MR, Galvin K, O\u2019Sullivan B, MacDonald CD, Ching EWK, Turkheimer F, et al. Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci. 2014;264:285\u201396.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102752","volume":"63","author":"NA Uranova","year":"2021","unstructured":"Uranova NA, Vikhreva OV, Rakhmanova VI. Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia. Asian J Psychiatry. 2021;63:102752.","journal-title":"Asian J Psychiatry"},{"key":"2861_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.17116\/jnevro202112112177","volume":"121","author":"OV Vikhreva","year":"2021","unstructured":"Vikhreva OV, Uranova NA. Reaktivnost\u2019 mikroglii v prefrontal\u2019noi kore pri raznykh tipakh techeniya shizofrenii. Zh nevrologii i psikhiatrii Im S S Korsakova. 2021;121:77\u201383.","journal-title":"Zh nevrologii i psikhiatrii Im S S Korsakova"},{"key":"2861_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.4","volume":"7","author":"van Kesteren","year":"2017","unstructured":"van Kesteren, Gremmels CFMG, Witte H, de LD, Hol EM, van Gool AR, et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. 2017;7:e1075.","journal-title":"Transl Psychiatry"},{"key":"2861_CR31","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.23962","volume":"69","author":"GJLJ Snijders","year":"2021","unstructured":"Snijders GJLJ, van Zuiden W, Sneeboer MAM, van Berdenis Berlekom A, van der Geest AT, Schnieder T, et al. A loss of mature microglial markers without immune activation in schizophrenia. Glia. 2021;69:1251\u201367.","journal-title":"Glia"},{"key":"2861_CR32","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-01879-0","volume":"12","author":"J Fessel","year":"2022","unstructured":"Fessel J. Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients. Transl Psychiatry. 2022;12:120.","journal-title":"Transl Psychiatry"},{"key":"2861_CR33","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1523\/JNEUROSCI.2922-20.2021","volume":"41","author":"X Hu","year":"2021","unstructured":"Hu X, Xiao G, He L, Niu X, Li H, Lou T, et al. Sustained ErbB Activation Causes Demyelination and Hypomyelination by Driving Necroptosis of Mature Oligodendrocytes and Apoptosis of Oligodendrocyte Precursor Cells. J Neurosci. 2021;41:9872\u201390.","journal-title":"J Neurosci"},{"key":"2861_CR34","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/npp.2008.19","volume":"33","author":"P Katsel","year":"2008","unstructured":"Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, et al. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2008;33:2993\u20133009.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2861_CR35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.schres.2015.10.042","volume":"169","author":"SA Mauney","year":"2015","unstructured":"Mauney SA, Pietersen CY, Sonntag K-C, Woo T-UW. Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia. Schizophrenia Res. 2015;169:374\u201380.","journal-title":"Schizophrenia Res"},{"key":"2861_CR36","doi-asserted-by":"crossref","unstructured":"Raabe FJ, Slapakova L, Rossner MJ, Cantuti-Castelvetri L, Simons M, Falkai PG et al. Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. Cells. 2019;8:1496.","DOI":"10.3390\/cells8121496"},{"key":"2861_CR37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/schbul\/sbad065","volume":"49","author":"P Falkai","year":"2023","unstructured":"Falkai P, Rossner MJ, Raabe FJ, Wagner E, Keeser D, Maurus I, et al. Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis. Schizophr Bull. 2023;49:1614\u201324.","journal-title":"Schizophr Bull"},{"key":"2861_CR38","first-page":"46","volume":"21","author":"NS Kolomeets","year":"2024","unstructured":"Kolomeets NS. Oligodendrocyte Progenitors in Schizophrenia: The Role in Pathogenesis and Potential Treatment Target. \u041f\u0421\u0418\u0425\u0418\u0410\u0422\u0420\u0418\u042f. 2024;21:46\u201364.","journal-title":"\u041f\u0421\u0418\u0425\u0418\u0410\u0422\u0420\u0418\u042f"},{"key":"2861_CR39","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0618-z","volume":"9","author":"S Papiol","year":"2019","unstructured":"Papiol S, Keeser D, Hasan A, Schneider-Axmann T, Raabe F, Degenhardt F, et al. Polygenic burden associated to oligodendrocyte precursor cells and radial glia influences the hippocampal volume changes induced by aerobic exercise in schizophrenia patients. Transl Psychiatry. 2019;9:284.","journal-title":"Transl Psychiatry"},{"key":"2861_CR40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2023.04.003","volume":"46","author":"C Yi","year":"2023","unstructured":"Yi C, Verkhratsky A, Niu J. Pathological potential of oligodendrocyte precursor cells: terra incognita. Trends Neurosci. 2023;46:581\u201396.","journal-title":"Trends Neurosci"},{"key":"2861_CR41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cne.21974","volume":"513","author":"FAC Azevedo","year":"2009","unstructured":"Azevedo FAC, Carvalho LRB, Grinberg LT, Farfel JM, Ferretti REL, Leite REP, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009;513:532\u201341.","journal-title":"J Comp Neurol"},{"key":"2861_CR42","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1002\/cne.24040","volume":"524","author":"CS von Bartheld","year":"2016","unstructured":"von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting. J Comp Neurol. 2016;524:3865\u201395.","journal-title":"J Comp Neurol"},{"key":"2861_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/revneuro-2019-0020","volume":"31","author":"H-G Bernstein","year":"2019","unstructured":"Bernstein H-G, Keilhoff G, Dobrowolny H, Guest PC, Steiner J. Perineuronal oligodendrocytes in health and disease: the journey so far. Rev Neurosci. 2019;31:89\u201399.","journal-title":"Rev Neurosci"},{"key":"2861_CR44","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1030486","volume":"10","author":"Y Osanai","year":"2022","unstructured":"Osanai Y, Yamazaki R, Shinohara Y, Ohno N. Heterogeneity and regulation of oligodendrocyte morphology. Front cell Dev Biol. 2022;10:1030486.","journal-title":"Front cell Dev Biol"},{"key":"2861_CR45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41593-023-01558-3","volume":"27","author":"ZJ Looser","year":"2024","unstructured":"Looser ZJ, Faik Z, Ravotto L, Zanker HS, Jung RB, Werner HB, et al. Oligodendrocyte-axon metabolic coupling is mediated by extracellular K+ and maintains axonal health. Nat Neurosci. 2024;27:433\u201348.","journal-title":"Nat Neurosci"},{"key":"2861_CR46","doi-asserted-by":"crossref","unstructured":"Kuhn S, Gritti L, Crooks D, Dombrowski Y. Oligodendrocytes in Development, Myelin Generation and Beyond. Cells. 2019;8:1424.","DOI":"10.3390\/cells8111424"},{"key":"2861_CR47","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao J, Huang C-C, Zhang Y, Liu Y, Tsai S-J, Lin C-P, et al. Structure-function coupling in white matter uncovers the abnormal brain connectivity in Schizophrenia. Transl Psychiatry. 2023;13:214.","journal-title":"Transl Psychiatry"},{"key":"2861_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/npjschz.2015.34","volume":"1","author":"JS Cassoli","year":"2015","unstructured":"Cassoli JS, Guest PC, Malchow B, Schmitt A, Falkai P, Martins-de-Souza D. Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules. npj Schizophr. 2015;1:15034.","journal-title":"npj Schizophr"},{"key":"2861_CR49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5498\/wjp.v12.i2.264","volume":"12","author":"M Vald\u00e9s-Tovar","year":"2022","unstructured":"Vald\u00e9s-Tovar M, Rodr\u00edguez-Ram\u00edrez AM, Rodr\u00edguez-C\u00e1rdenas L, Sotelo-Ram\u00edrez CE, Camarena B, Sanabrais-Jim\u00e9nez MA, et al. Insights into myelin dysfunction in schizophrenia and bipolar disorder. World J Psychiatry. 2022;12:264\u201385.","journal-title":"World J Psychiatry"},{"key":"2861_CR50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/BPL-160033","volume":"2","author":"AL MacKay","year":"2016","unstructured":"MacKay AL, Laule C. Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin. Brain Plasticity. 2016;2:71\u201391.","journal-title":"Brain Plasticity"},{"key":"2861_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psychres.2006.12.019","volume":"151","author":"WT Regenold","year":"2007","unstructured":"Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res. 2007;151:179\u201388.","journal-title":"Psychiatry Res"},{"key":"2861_CR52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0361-9230(01)00528-7","volume":"55","author":"N Uranova","year":"2001","unstructured":"Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597\u2013610.","journal-title":"Brain Res Bull"},{"key":"2861_CR53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1461145707007626","volume":"10","author":"NA Uranova","year":"2007","unstructured":"Uranova NA, Vostrikov VM, Vikhreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD. The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol. 2007;10:537\u201345.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2861_CR54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41537-018-0068-2","volume":"4","author":"NA Uranova","year":"2018","unstructured":"Uranova NA, Vikhreva OV, Rakhmanova VI, Orlovskaya DD. Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia. npj Schizophr. 2018;4:26.","journal-title":"npj Schizophr"},{"key":"2861_CR55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jnr.23167","volume":"91","author":"J Rosenbluth","year":"2013","unstructured":"Rosenbluth J, Bobrowski-Khoury N. Structural bases for central nervous system malfunction in the quaking mouse: dysmyelination in a potential model of schizophrenia. J Neurosci Res. 2013;91:374\u201381.","journal-title":"J Neurosci Res"},{"key":"2861_CR56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpsychires.2009.07.007","volume":"44","author":"D Martins-de-Souza","year":"2010","unstructured":"Martins-de-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiatr Res. 2010;44:149\u201356.","journal-title":"J Psychiatr Res"},{"key":"2861_CR57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/15622975.2020.1789217","volume":"22","author":"D Martins-de-Souza","year":"2021","unstructured":"Martins-de-Souza D, Guest PC, Reis-de-Oliveira G, Schmitt A, Falkai P, Turck CW. An overview of the human brain myelin proteome and differences associated with schizophrenia. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2021;22:271\u201387.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR58","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/schbul\/sbt109","volume":"40","author":"A Goudriaan","year":"2014","unstructured":"Goudriaan A, de Leeuw C, Ripke S, Hultman CM, Sklar P, Sullivan PF, et al. Specific glial functions contribute to schizophrenia susceptibility. Schizophrenia Bull. 2014;40:925\u201335.","journal-title":"Schizophrenia Bull"},{"key":"2861_CR59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.mp.4002096","volume":"13","author":"G Karoutzou","year":"2008","unstructured":"Karoutzou G, Emrich HM, Dietrich DE. The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry. 2008;13:245\u201360.","journal-title":"Mol Psychiatry"},{"key":"2861_CR60","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","volume":"98","author":"Y Hakak","year":"2001","unstructured":"Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 2001;98:4746\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2861_CR61","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","volume":"362","author":"D Tkachev","year":"2003","unstructured":"Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798\u2013805.","journal-title":"Lancet"},{"key":"2861_CR62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jnr.20208","volume":"77","author":"C Aston","year":"2004","unstructured":"Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004;77:858\u201366.","journal-title":"J Neurosci Res"},{"key":"2861_CR63","doi-asserted-by":"crossref","unstructured":"Schoeneck L, Movebach J, Meyer-Lotz G, Keilhoff G, Mawrin C, Dobrowolny H et al. Dyregulated expression of the oligodendroglial transcriptionfactor Olig 2 in schizophrenia and depression. Pharmacopsychiatry. 2009;42:2227\u201342.","DOI":"10.1055\/s-0029-1240222"},{"key":"2861_CR64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/15622970903497936","volume":"11","author":"N Farkas","year":"2010","unstructured":"Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, et al. Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2010;11:556\u201366.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR65","doi-asserted-by":"crossref","first-page":"e38211","DOI":"10.1371\/journal.pone.0038211","volume":"7","author":"PR Matthews","year":"2012","unstructured":"Matthews PR, Eastwood SL, Harrison PJ. Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PloS One. 2012;7:e38211.","journal-title":"PloS One"},{"key":"2861_CR66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2006.08.071","volume":"1120","author":"G Novak","year":"2006","unstructured":"Novak G, Tallerico T. Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA\/TATC polymorphism in 3\u2019-UTR. Brain Res. 2006;1120:161\u201371.","journal-title":"Brain Res"},{"key":"2861_CR67","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jpsychires.2007.10.001","volume":"42","author":"J Steiner","year":"2008","unstructured":"Steiner J, Bernstein H-G, Bielau H, Farkas N, Winter J, Dobrowolny H, et al. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res. 2008;42:868\u201376.","journal-title":"J Psychiatr Res"},{"key":"2861_CR68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2007.12.474","volume":"100","author":"VZ Chong","year":"2008","unstructured":"Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophrenia Res. 2008;100:270\u201380.","journal-title":"Schizophrenia Res"},{"key":"2861_CR69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12017-012-8185-y","volume":"14","author":"H-G Bernstein","year":"2012","unstructured":"Bernstein H-G, Smalla K-H, D\u00fcrrschmidt D, Keilhoff G, Dobrowolny H, Steiner J, et al. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med. 2012;14:270\u201380.","journal-title":"Neuromolecular Med"},{"key":"2861_CR70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00406-015-0640-y","volume":"266","author":"H-G Bernstein","year":"2016","unstructured":"Bernstein H-G, Jauch E, Dobrowolny H, Mawrin C, Steiner J, Bogerts B. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2016;266:495\u2013504.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR71","unstructured":"Uranova NA, Orlovskaia DD, Vikhreva OV, Zimina IS, Rakhmanova VI. Morfometricheskaia otsenka ul\u2019trastrukturnykh plasticheskikh perestroek v mozge pri \u00e9ndogennykh psikhozakh (reaktsii oligodendroglii). Vestnik Rossiiskoi akademii meditsinskikh nauk. 2001:42\u20138."},{"key":"2861_CR72","first-page":"52","volume":"108","author":"NS Kolomeets","year":"2008","unstructured":"Kolomeets NS, Uranova NA. Pathology of oligodendroglia and myelinated fibers of the hippocampus in schizophrenia (an ultrastructural and morphometric study). Zh Nevrologii i Psikhiatrii Im S S Korsakova. 2008;108:52\u201360.","journal-title":"Zh Nevrologii i Psikhiatrii Im S S Korsakova"},{"key":"2861_CR73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2016.04.023","volume":"177","author":"OV Vikhreva","year":"2016","unstructured":"Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophrenia Res. 2016;177:28\u201336.","journal-title":"Schizophrenia Res"},{"key":"2861_CR74","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1023\/A:1020981510759","volume":"27","author":"PR Hof","year":"2002","unstructured":"Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 2002;27:1193\u20131200.","journal-title":"Neurochem Res"},{"key":"2861_CR75","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0006-3223(03)00237-3","volume":"53","author":"PR Hof","year":"2003","unstructured":"Hof PR, Haroutunian V, Friedrich VL, Byne W, Buitron C, Perl DP, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry. 2003;53:1075\u201385.","journal-title":"Biol Psychiatry"},{"key":"2861_CR76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2010.04.012","volume":"120","author":"D Kerns","year":"2010","unstructured":"Kerns D, Vong GS, Barley K, Dracheva S, Katsel P, Casaccia P, et al. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophrenia Res. 2010;120:150\u20138.","journal-title":"Schizophrenia Res"},{"key":"2861_CR77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-008-0379-x","volume":"117","author":"D Segal","year":"2009","unstructured":"Segal D, Schmitz C, Hof PR. Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathologica. 2009;117:385\u201394.","journal-title":"Acta Neuropathologica"},{"key":"2861_CR78","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2990.2012.01296.x","volume":"39","author":"M H\u00f6istad","year":"2013","unstructured":"H\u00f6istad M, Heinsen H, Wicinski B, Schmitz C, Hof PR. Stereological assessment of the dorsal anterior cingulate cortex in schizophrenia: absence of changes in neuronal and glial densities. Neuropathol Appl Neurobiol. 2013;39:348\u201361.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2861_CR79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15622970701210247","volume":"9","author":"V Vostrikov","year":"2008","unstructured":"Vostrikov V, Orlovskaya D, Uranova N. Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia. World J Biol Psychiatry. 2008;9:34\u201342.","journal-title":"World J Biol Psychiatry"},{"key":"2861_CR80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.04.014","volume":"94","author":"VM Vostrikov","year":"2007","unstructured":"Vostrikov VM, Uranova NA, Orlovskaya DD. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophrenia Res. 2007;94:273\u201380.","journal-title":"Schizophrenia Res"},{"key":"2861_CR81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00406-018-0888-0","volume":"269","author":"NS Kolomeets","year":"2019","unstructured":"Kolomeets NS, Uranova NA. Reduced oligodendrocyte density in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2019;269:379\u201386.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR82","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00406-021-01353-w","volume":"272","author":"NS Kolomeets","year":"2022","unstructured":"Kolomeets NS, Uranova NA. Reduced number of satellite oligodendrocytes of pyramidal neurons in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2022;272:947\u201355.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-neuro-080317-061853","volume":"41","author":"M Monje","year":"2018","unstructured":"Monje M. Myelin Plasticity and Nervous System Function. Annu Rev Neurosci. 2018;41:61\u201376.","journal-title":"Annu Rev Neurosci"},{"key":"2861_CR84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517\u201321.","journal-title":"Nature"},{"key":"2861_CR85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134594","volume":"715","author":"I Kimura","year":"2020","unstructured":"Kimura I, Dohgu S, Takata F, Matsumoto J, Watanabe T, Iwao T, et al. Oligodendrocytes upregulate blood-brain barrier function through mechanisms other than the PDGF-BB\/PDGFR\u03b1 pathway in the barrier-tightening effect of oligodendrocyte progenitor cells. Neurosci Lett. 2020;715:134594.","journal-title":"Neurosci Lett"},{"key":"2861_CR86","first-page":"576","volume":"20","author":"A Verkhratsky","year":"2014","unstructured":"Verkhratsky A, Rodr\u00edguez JJ, Steardo L. Astrogliopathology: a central element of neuropsychiatric diseases? Neuroscientist Rev J Bringing Neurobiol Neurol Psychiatry. 2014;20:576\u201388.","journal-title":"Neuroscientist Rev J Bringing Neurobiol Neurol Psychiatry"},{"key":"2861_CR87","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2015.03.025","volume":"85","author":"A Verkhratsky","year":"2016","unstructured":"Verkhratsky A, Parpura V. Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders. Neurobiol Dis. 2016;85:254\u201361.","journal-title":"Neurobiol Dis"},{"key":"2861_CR88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-319-45096-4_12","volume":"13","author":"A Verkhratsky","year":"2016","unstructured":"Verkhratsky A, Steardo L, Peng L, Parpura V. Astroglia, Glutamatergic Transmission and Psychiatric Diseases. Adv Neurobiol. 2016;13:307\u201326.","journal-title":"Adv Neurobiol"},{"key":"2861_CR89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M. Physiology of Astroglia. Physiological Rev. 2018;98:239\u2013389.","journal-title":"Physiological Rev"},{"key":"2861_CR90","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/15622975.2021.1939155","volume":"23","author":"C Prats","year":"2022","unstructured":"Prats C, Fatj\u00f3-Vilas M, Penzol MJ, Kebir O, Pina-Camacho L, Demontis D, et al. Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2022;23:208\u201318.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR91","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mco2.108","volume":"2","author":"X Liu","year":"2021","unstructured":"Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L, et al. The role of necroptosis in disease and treatment. MedComm. 2021;2:730\u201355.","journal-title":"MedComm"},{"key":"2861_CR92","doi-asserted-by":"crossref","unstructured":"Chapman TW, Kamen Y, Piedra ET, Hill RA. Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination. J Neurosci. 2024;44:e1794232024.","DOI":"10.1523\/JNEUROSCI.1794-23.2024"},{"key":"2861_CR93","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/febs.16190","volume":"289","author":"M Irfan","year":"2022","unstructured":"Irfan M, Evonuk KS, De Silva TM. Microglia phagocytose oligodendrocyte progenitor cells and synapses during early postnatal development: implications for white versus gray matter maturation. FEBS J. 2022;289:2110\u201327.","journal-title":"FEBS J"},{"key":"2861_CR94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2019.00186","volume":"10","author":"C Brand\u00e3o-Teles","year":"2019","unstructured":"Brand\u00e3o-Teles C, de Almeida V, Cassoli JS, Martins-de-Souza D. Biochemical Pathways Triggered by Antipsychotics in Human corrected Oligodendrocytes: Potential of Discovering New Treatment Targets. Front Pharmacol. 2019;10:186.","journal-title":"Front Pharmacol"},{"key":"2861_CR95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69543-5","volume":"10","author":"G Seabra","year":"2020","unstructured":"Seabra G, de Almeida V, Reis-de-Oliveira G, Crunfli F, Antunes ASLM, Martins-de-Souza D. Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia. Sci Rep. 2020;10:12655.","journal-title":"Sci Rep"},{"key":"2861_CR96","volume":"134","author":"H-G Bernstein","year":"2020","unstructured":"Bernstein H-G, Keilhoff G, Dobrowolny H, Steiner J. Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia. Med Hypotheses. 2020;134:109443.","journal-title":"Med Hypotheses"},{"key":"2861_CR97","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","volume":"63","author":"GT Konopaske","year":"2008","unstructured":"Konopaske GT, Dorph-Petersen K-A, Sweet RA, Pierri JN, Zhang W, Sampson AR, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry. 2008;63:759\u201365.","journal-title":"Biol Psychiatry"},{"key":"2861_CR98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","volume":"138","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhang H, Wang L, Jiang W, Xu H, Xiao L, et al. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophrenia Res. 2012;138:8\u201317.","journal-title":"Schizophrenia Res"},{"key":"2861_CR99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-024-05222-2","volume":"81","author":"H Khelfaoui","year":"2024","unstructured":"Khelfaoui H, Ibaceta-Gonzalez C, Angulo MC. Functional myelin in cognition and neurodevelopmental disorders. Cell Mol Life Sci CMLS. 2024;81:181.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2861_CR100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0165-6147(00)01494-2","volume":"21","author":"V Gallo","year":"2000","unstructured":"Gallo V, Ghiani CA. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci. 2000;21:252\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"2861_CR101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0091-3057(94)00267-M","volume":"50","author":"EM Nikulina","year":"1995","unstructured":"Nikulina EM, Skrinskaya JA, Avgustinovich DF, Popova NK. Dopaminergic brain system in the quaking mutant mouse. Pharmacol Biochem Behav. 1995;50:333\u20137.","journal-title":"Pharmacol Biochem Behav"},{"key":"2861_CR102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pneurobio.2010.09.004","volume":"93","author":"N Takahashi","year":"2011","unstructured":"Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93:13\u201324.","journal-title":"Prog Neurobiol"},{"key":"2861_CR103","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00424-023-02837-5","volume":"475","author":"L-P Fang","year":"2023","unstructured":"Fang L-P, Bai X. Oligodendrocyte precursor cells: the multitaskers in the brain. Pflugers Archiv. Eur J Physiol. 2023;475:1035\u201344.","journal-title":"Eur J Physiol"},{"key":"2861_CR104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.05.005.2009","volume":"3","author":"I Jakovcevski","year":"2009","unstructured":"Jakovcevski I, Filipovic R, Mo Z, Rakic S, Zecevic N. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat. 2009;3:5.","journal-title":"Front Neuroanat"},{"key":"2861_CR105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1523\/JNEUROSCI.2106-10.2011","volume":"31","author":"SCL Deoni","year":"2011","unstructured":"Deoni SCL, Mercure E, Blasi A, Gasston D, Thomson A, Johnson M, et al. Mapping infant brain myelination with magnetic resonance imaging. J Neurosci. 2011;31:784\u201391.","journal-title":"J Neurosci"},{"key":"2861_CR106","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cell.2020.06.027","volume":"182","author":"W Huang","year":"2020","unstructured":"Huang W, Bhaduri A, Velmeshev D, Wang S, Wang L, Rottkamp CA, et al. Origins and Proliferative States of Human Oligodendrocyte Precursor Cells. Cell. 2020;182:594\u2013608.e11.","journal-title":"Cell"},{"key":"2861_CR107","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.bbamcr.2014.04.018","volume":"1843","author":"A Barateiro","year":"2014","unstructured":"Barateiro A, Fernandes A. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim Biophys Acta. 2014;1843:1917\u201329.","journal-title":"Biochim Biophys Acta"},{"key":"2861_CR108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M","volume":"43","author":"A Nishiyama","year":"1996","unstructured":"Nishiyama A, Lin X-H, Giese N, Heldin C-H, Stallcup WB. Interaction between NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells is required for optimal response to PDGF. J Neurosci Res. 1996;43:315\u201330.","journal-title":"J Neurosci Res."},{"key":"2861_CR109","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/glia.21237","volume":"59","author":"E Boda","year":"2011","unstructured":"Boda E, Vigan\u00f2 F, Rosa P, Fumagalli M, Labat-Gest V, Tempia F, et al. The GPR17 receptor in NG2 expressing cells: focus on in vivo cell maturation and participation in acute trauma and chronic damage. Glia. 2011;59:1958\u201373.","journal-title":"Glia"},{"key":"2861_CR110","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1038\/s41380-022-01777-3","volume":"27","author":"G Yu","year":"2022","unstructured":"Yu G, Su Y, Guo C, Yi C, Yu B, Chen H, et al. Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model. Mol Psychiatry. 2022;27:5154\u201366.","journal-title":"Mol Psychiatry"},{"key":"2861_CR111","doi-asserted-by":"crossref","unstructured":"Rivera AD, Normanton JR, Butt AM, Azim K. The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials. Int J Mol Sci. 2024;25:4452.","DOI":"10.3390\/ijms25084452"},{"key":"2861_CR112","unstructured":"Bernstein H-G, St\u00fcrze E, Bogerts B. Cell cycle disturbances in schizophrenia: The journey so far. Acta Clin Croatica. 2010;49:33\u20135."},{"key":"2861_CR113","doi-asserted-by":"crossref","first-page":"22184","DOI":"10.1074\/jbc.M112.366179","volume":"287","author":"S Jepson","year":"2012","unstructured":"Jepson S, Vought B, Gross CH, Gan L, Austen D, Frantz JD, et al. LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions. J Biol Chem. 2012;287:22184\u201395.","journal-title":"J Biol Chem"},{"key":"2861_CR114","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.121","volume":"4","author":"F Fernandez-Enright","year":"2014","unstructured":"Fernandez-Enright F, Andrews JL, Newell KA, Pantelis C, Huang XF. Novel implications of Lingo-1 and its signaling partners in schizophrenia. Transl Psychiatry. 2014;4:e348.","journal-title":"Transl Psychiatry"},{"key":"2861_CR115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcp.1041570211","volume":"157","author":"AJ Roskams","year":"1993","unstructured":"Roskams AJ, Friedman V, Wood CM, Walker L, Owens GA, Stewart DA, et al. Cell cycle activity and expression of prohibitin mRNA. J Cell Physiol. 1993;157:289\u201395.","journal-title":"J Cell Physiol"},{"key":"2861_CR116","doi-asserted-by":"crossref","first-page":"e88506","DOI":"10.1371\/journal.pone.0088506","volume":"9","author":"T Hattori","year":"2014","unstructured":"Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, et al. DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PloS One. 2014;9:e88506.","journal-title":"PloS One"},{"key":"2861_CR117","doi-asserted-by":"crossref","unstructured":"Pieczonka K, Khazaei M, Fehlings MG. Promoting the Differentiation of Neural Progenitor Cells into Oligodendrocytes through the Induction of Olig2 Expression: A Transcriptomic Study Using RNA-seq Analysis. Cells. 2023;12:1252.","DOI":"10.3390\/cells12091252"},{"key":"2861_CR118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.lfs.2013.08.004","volume":"93","author":"F Fang","year":"2013","unstructured":"Fang F, Zhang H, Zhang Y, Xu H, Huang Q, Adilijiang A, et al. Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2. Life Sci. 2013;93:429\u201334.","journal-title":"Life Sci"},{"key":"2861_CR119","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E4","volume":"24","author":"YA Syed","year":"2008","unstructured":"Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MR. Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurgical Focus. 2008;24:E5.","journal-title":"Neurosurgical Focus"},{"key":"2861_CR120","volume":"10","author":"R S\u00e1nchez-Gonz\u00e1lez","year":"2020","unstructured":"S\u00e1nchez-Gonz\u00e1lez R, Bribi\u00e1n A, L\u00f3pez-Mascaraque L. Cell Fate Potential of NG2 Progenitors. Sci Rep. 2020;10:9876.","journal-title":"Sci Rep"},{"key":"2861_CR121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2019.10.027","volume":"215","author":"VM Vostrikov","year":"2020","unstructured":"Vostrikov VM, Uranova NA. Reduced density of oligodendrocytes and oligodendrocyte clusters in the caudate nucleus in major psychiatric illnesses. Schizophrenia Res. 2020;215:211\u20136.","journal-title":"Schizophrenia Res"},{"key":"2861_CR122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17116\/jnevro201911912162","volume":"119","author":"NS Kolomeets","year":"2019","unstructured":"Kolomeets NS, Vostrikov VM, Uranova NA. Narusheniia klasterizatsii oligodendrotsitov v supra- i infragranuliarnykh sloiakh polia 10 prefrontal\u2019no\u012d kory pri shizofrenii. Zh Nevrologii i Psikhiatrii Im S S Korsakova. 2019;119:62\u20138.","journal-title":"Zh Nevrologii i Psikhiatrii Im S S Korsakova"},{"key":"2861_CR123","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuint.2010.07.003","volume":"57","author":"T Yamauchi","year":"2010","unstructured":"Yamauchi T, Tatsumi K, Makinodan M, Kimoto S, Toritsuka M, Okuda H, et al. Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus. Neurochemistry Int. 2010;57:565\u201371.","journal-title":"Neurochemistry Int"},{"key":"2861_CR124","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.pnpbp.2011.07.011","volume":"35","author":"S Kimoto","year":"2011","unstructured":"Kimoto S, Okuda A, Toritsuka M, Yamauchi T, Makinodan M, Okuda H, et al. Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures. Prog Neuro Psychopharmacol Biol Psychiatry. 2011;35:1950\u20136.","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"2861_CR125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2010.02.1068","volume":"119","author":"H Wang","year":"2010","unstructured":"Wang H, Xu H, Niu J, Mei F, Li X, Kong J, et al. Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain. Schizophrenia Res. 2010;119:164\u201374.","journal-title":"Schizophrenia Res"},{"key":"2861_CR126","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.mp.4002064","volume":"13","author":"L Xiao","year":"2008","unstructured":"Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry. 2008;13:697\u2013708.","journal-title":"Mol Psychiatry"},{"key":"2861_CR127","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuint.2018.04.001","volume":"118","author":"G Mi","year":"2018","unstructured":"Mi G, Wang Y, Ye E, Gao Y, Liu Q, Chen P, et al. The antipsychotic drug quetiapine stimulates oligodendrocyte differentiation by modulating the cell cycle. Neurochemistry Int. 2018;118:242\u201351.","journal-title":"Neurochemistry Int"},{"key":"2861_CR128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00406-011-0197-3","volume":"261","author":"J Steiner","year":"2011","unstructured":"Steiner J, Sarnyai Z, Westphal S, Gos T, Bernstein H-G, Bogerts B, et al. Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur Arch Psychiatry Clin Neurosci. 2011;261:477\u201382.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2861_CR129","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","volume":"78","author":"J Spaas","year":"2021","unstructured":"Spaas J, van Veggel L, Schepers M, Tiane A, van Horssen J, Wilson DM, et al. Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders. Cell Mol Life Sci CMLS. 2021;78:4615\u201337.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2861_CR130","volume":"7","author":"DA Maas","year":"2017","unstructured":"Maas DA, Vall\u00e8s A, Martens GJM. Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry. 2017;7:e1171.","journal-title":"Transl Psychiatry"},{"key":"2861_CR131","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2023.1256455","volume":"17","author":"I Toudji","year":"2023","unstructured":"Toudji I, Toumi A, Chamberland \u00c9, Rossignol E. Interneuron odyssey: molecular mechanisms of tangential migration. Front Neural Circuits. 2023;17:1256455.","journal-title":"Front Neural Circuits"},{"key":"2861_CR132","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV. Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. Trends Immunol. 2020;41:758\u201370.","journal-title":"Trends Immunol"},{"key":"2861_CR133","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fnagi.2018.00337","volume":"10","author":"AL Palmer","year":"2018","unstructured":"Palmer AL, Ousman SS. Astrocytes and Aging. Front Aging Neurosci. 2018;10:337.","journal-title":"Front Aging Neurosci"},{"key":"2861_CR134","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/1673-5374.379047","volume":"19","author":"M Zhou","year":"2024","unstructured":"Zhou M, Zhong S, Verkhratsky A. Astrocyte syncytium: from neonatal genesis to aging degeneration. Neural Regeneration Res. 2024;19:395\u20136.","journal-title":"Neural Regeneration Res"},{"key":"2861_CR135","doi-asserted-by":"crossref","unstructured":"Kim Y, Park J, Choi YK. The Role of Astrocytes in the Central Nervous System Focused on BK Channel and Heme Oxygenase Metabolites: A Review. Antioxidants. 2019;8:121.","DOI":"10.3390\/antiox8050121"},{"key":"2861_CR136","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0278-5846(03)00078-2","volume":"27","author":"GS Burbaeva","year":"2003","unstructured":"Burbaeva GS, Boksha IS, Turishcheva MS, Vorobyeva EA, Savushkina OK, Tereshkina EB. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatry. 2003;27:675\u201380.","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"2861_CR137","first-page":"192","volume":"11","author":"B Mitterauer","year":"2005","unstructured":"Mitterauer B. Nonfunctional glial proteins in tripartite synapses: a pathophysiological model of schizophrenia. Neuroscientist Rev J Bringing Neurobiol Neurol Psychiatry. 2005;11:192\u20138.","journal-title":"Neuroscientist Rev J Bringing Neurobiol Neurol Psychiatry"},{"key":"2861_CR138","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00702-009-0312-z","volume":"116","author":"Habl","year":"2009","unstructured":"Habl, Zink G, Petroianu M, Bauer G, Schneider-Axmann M, Wilmsdorff T, et al. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm. 2009;116:1657\u201365.","journal-title":"J Neural Transm"},{"key":"2861_CR139","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","volume":"11","author":"NA Uranova","year":"2010","unstructured":"Uranova NA, Zimina IS, Vikhreva OV, Krukov NO, Rachmanova VI, Orlovskaya DD. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2010;11:567\u201378.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","volume":"13","author":"J Steiner","year":"2012","unstructured":"Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein H-G, et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2012;13:482\u201392.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2013.12.013","volume":"152","author":"EMP Poels","year":"2014","unstructured":"Poels EMP, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, et al. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophrenia Res. 2014;152:325\u201332.","journal-title":"Schizophrenia Res"},{"key":"2861_CR142","doi-asserted-by":"crossref","unstructured":"Bryll A, Skrzypek J, Krzy\u015bciak W, Szel\u0105gowska M, \u015amierciak N, Kozicz T et al. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia. Biomolecules. 2020;10:384.","DOI":"10.3390\/biom10030384"},{"key":"2861_CR143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","volume":"56","author":"RC Roberts","year":"2021","unstructured":"Roberts RC. Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies. Mitochondrion. 2021;56:91\u2013101.","journal-title":"Mitochondrion"},{"key":"2861_CR144","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/glia.24221","volume":"70","author":"EC Oliveira Figueiredo","year":"2022","unstructured":"Oliveira Figueiredo EC, de, Cal\u00ec C, Petrelli F, Bezzi P. Emerging evidence for astrocyte dysfunction in schizophrenia. Glia. 2022;70:1585\u2013604.","journal-title":"Glia"},{"key":"2861_CR145","doi-asserted-by":"crossref","unstructured":"de Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, et al. Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment. Antioxidants. 2023;12:975.","DOI":"10.3390\/antiox12040975"},{"key":"2861_CR146","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1358450","volume":"18","author":"D Laricchiuta","year":"2024","unstructured":"Laricchiuta D, Papi M, Decandia D, Panuccio A, Cutuli D, Peciccia M, et al. The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects. Front Cell Neurosci. 2024;18:1358450.","journal-title":"Front Cell Neurosci"},{"key":"2861_CR147","doi-asserted-by":"crossref","unstructured":"Stanca S, Rossetti M, Bokulic Panichi L, Bongioanni P. The Cellular Dysfunction of the Brain-Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia. Int J Mol Sci. 2024;25:1250.","DOI":"10.3390\/ijms25021250"},{"key":"2861_CR148","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuroscience.2005.02.037","volume":"133","author":"MJ Webster","year":"2005","unstructured":"Webster MJ, O\u2019Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience. 2005;133:453\u201361.","journal-title":"Neuroscience"},{"key":"2861_CR149","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2006.05.067","volume":"404","author":"CT Toro","year":"2006","unstructured":"Toro CT, Hallak JEC, Dunham JS, Deakin JFW. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett. 2006;404:276\u201381.","journal-title":"Neurosci Lett"},{"key":"2861_CR150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2013.07.024","volume":"150","author":"AH Feresten","year":"2013","unstructured":"Feresten AH, Barakauskas V, Ypsilanti A, Barr AM, Beasley CL. Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness. Schizophrenia Res. 2013;150:252\u20137.","journal-title":"Schizophrenia Res"},{"key":"2861_CR151","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0004867414531078","volume":"48","author":"VS Catts","year":"2014","unstructured":"Catts VS, Wong J, Fillman SG, Fung SJ, Shannon Weickert C. Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation. Aust NZ J Psychiatry. 2014;48:722\u201334.","journal-title":"Aust NZ J Psychiatry"},{"key":"2861_CR152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71060-4","volume":"10","author":"Rodrigues-Amorim","year":"2020","unstructured":"Rodrigues-Amorim, Rivera-Baltan\u00e1s D, del Carmen Vallejo-Curto T, Rodriguez-Jamardo M, las Heras C, de E, et al. Plasma \u03b2-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia. Sci Rep. 2020;10:14271.","journal-title":"Sci Rep"},{"key":"2861_CR153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2004.12.012","volume":"75","author":"EG Bruneau","year":"2005","unstructured":"Bruneau EG, McCullumsmith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophrenia Res. 2005;75:27\u201334.","journal-title":"Schizophrenia Res"},{"key":"2861_CR154","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/npp.2010.252","volume":"36","author":"P Katsel","year":"2011","unstructured":"Katsel P, Byne W, Roussos P, Tan W, Siever L, Haroutunian V. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2011;36:1171\u20137.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2861_CR155","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2174\/18715273113129990091","volume":"12","author":"H-G Bernstein","year":"2013","unstructured":"Bernstein H-G, Tausch A, Wagner R, Steiner J, Seeleke P, Walter M. et al. Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurological Disord Drug Targets. 2013;12:900\u201313.","journal-title":"CNS Neurological Disord Drug Targets"},{"key":"2861_CR156","doi-asserted-by":"crossref","unstructured":"Mi\u00fcller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl. 2007;72:269\u201380.","DOI":"10.1007\/978-3-211-73574-9_33"},{"key":"2861_CR157","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/mp.2015.148","volume":"21","author":"RE McCullumsmith","year":"2016","unstructured":"McCullumsmith RE, O\u2019Donovan SM, Drummond JB, Benesh FS, Simmons M, Roberts R, et al. Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons? Mol Psychiatry. 2016;21:823\u201330.","journal-title":"Mol Psychiatry"},{"key":"2861_CR158","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2006.09.013","volume":"31","author":"M Rothermundt","year":"2007","unstructured":"Rothermundt M, Ohrmann P, Abel S, Siegmund A, Pedersen A, Ponath G, et al. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuro Psychopharmacol Biol Psychiatry. 2007;31:361\u20134.","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"2861_CR159","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41386-018-0028-6","volume":"43","author":"SM O\u2019Donovan","year":"2018","unstructured":"O\u2019Donovan SM, Sullivan C, Koene R, Devine E, Hasselfeld K, Moody CL, et al. Cell-subtype-specific changes in adenosine pathways in schizophrenia. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2018;43:1667\u201374.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2861_CR160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/npp.2017.242","volume":"43","author":"H-G Bernstein","year":"2018","unstructured":"Bernstein H-G, Dobrowolny H, Keilhoff G, Bogerts B, Steiner J. Reduced Density of DISC1 Expressing Astrocytes in the Dentate Gyrus but not in the Subventricular Zone in Schizophrenia. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2018;43:457\u20138.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2861_CR161","first-page":"19","volume":"42","author":"HG Bernstein","year":"1992","unstructured":"Bernstein HG, Kirschke H, Wiederanders B, Khudoerkov RM, Hinz W, Rinne A. Lysosomal proteinases as putative diagnostic tools in human neuropathology: Alzheimer disease (AD) and schizophrenia. Acta Histochemica Supplementband. 1992;42:19\u201324.","journal-title":"Acta Histochemica Supplementband"},{"key":"2861_CR162","first-page":"48","volume":"91","author":"AI O\u012dfa","year":"1991","unstructured":"O\u012dfa AI, Uranova NA. Elektronno-mikroskopicheski\u012d analiz tsitoarkhitektonicheskikh narusheni\u012d v kore golovnogo mozga pri shizofrenii. Zh Nevropatologii i Psikhiatrii Im S S Korsakova. 1991;91:48\u201352.","journal-title":"Zh Nevropatologii i Psikhiatrii Im S S Korsakova"},{"key":"2861_CR163","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0920-9964(96)00059-X","volume":"22","author":"NA Uranova","year":"1996","unstructured":"Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD, Denisov DV. Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients. Schizophrenia Res. 1996;22:81\u20133.","journal-title":"Schizophrenia Res"},{"key":"2861_CR164","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/15622970902806124","volume":"11","author":"NS Kolomeets","year":"2010","unstructured":"Kolomeets NS, Uranova N. Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study. World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry. 2010;11:282\u201392.","journal-title":"World J Biol Psychiatry Off J World Federation Societies Biol Psychiatry"},{"key":"2861_CR165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44192-0","volume":"14","author":"A Popov","year":"2023","unstructured":"Popov A, Brazhe N, Morozova K, Yashin K, Bychkov M, Nosova O, et al. Mitochondrial malfunction and atrophy of astrocytes in the aged human cerebral cortex. Nat Commun. 2023;14:8380.","journal-title":"Nat Commun"},{"key":"2861_CR166","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biopsych.2010.08.027","volume":"69","author":"TP Schnieder","year":"2011","unstructured":"Schnieder TP, Dwork AJ. Searching for neuropathology: gliosis in schizophrenia. Biol Psychiatry. 2011;69:134\u20139.","journal-title":"Biol Psychiatry"},{"key":"2861_CR167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.1986.01800010033004","volume":"43","author":"FM Benes","year":"1986","unstructured":"Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen psychiatry. 1986;43:31\u20135.","journal-title":"Arch Gen psychiatry"},{"key":"2861_CR168","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archpsyc.55.3.215","volume":"55","author":"G Rajkowska","year":"1998","unstructured":"Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215\u201324.","journal-title":"Arch Gen Psychiatry"},{"key":"2861_CR169","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1503\/jpn.130277","volume":"39","author":"C Hercher","year":"2014","unstructured":"Hercher C, Chopra V, Beasley CL. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci. 2014;39:376\u201385.","journal-title":"J Psychiatry Neurosci"},{"key":"2861_CR170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2990.1999.00162.x","volume":"25","author":"P Falkai","year":"1999","unstructured":"Falkai P, Honer WG, David S, Bogerts B, Majtenyi C, Bayer TA. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol. 1999;25:48\u201353.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2861_CR171","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0361-9230(01)00529-9","volume":"55","author":"R Damadzic","year":"2001","unstructured":"Damadzic R, Bigelow LB, Krimer LS, Goldenson DA, Saunders RC, Kleinman JE, et al. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. Brain Res Bull. 2001;55:611\u20138.","journal-title":"Brain Res Bull"},{"key":"2861_CR172","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0006-3223(88)90144-8","volume":"24","author":"CD Stevens","year":"1988","unstructured":"Stevens CD, Altshuler LL, Bogerts B, Falkai P. Quantitative study of gliosis in schizophrenia and Huntington\u2019s chorea. Biol Psychiatry. 1988;24:697\u2013700.","journal-title":"Biol Psychiatry"},{"key":"2861_CR173","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","volume":"21","author":"MO Tr\u00e9panier","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry. 2016;21:1009\u201326.","journal-title":"Mol Psychiatry"},{"key":"2861_CR174","doi-asserted-by":"crossref","unstructured":"Xu J. New Insights into GFAP Negative Astrocytes in Calbindin D28k Immunoreactive Astrocytes. Brain Sci. 2018;8:143.","DOI":"10.3390\/brainsci8080143"},{"key":"2861_CR175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.stem.2017.06.012","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem MS, Osipovitch M, Liu Z, Bates J, Chandler-Militello D, Zou L, et al. Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia. Cell Stem Cell. 2017;21:195\u2013208.e6.","journal-title":"Cell Stem Cell"},{"key":"2861_CR176","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.celrep.2019.05.088","volume":"27","author":"Z Liu","year":"2019","unstructured":"Liu Z, Osipovitch M, Benraiss A, Huynh NPT, Foti R, Bates J, et al. Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling. Cell Rep. 2019;27:3832\u2013.e6.","journal-title":"Cell Rep"},{"key":"2861_CR177","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/schbul\/sbab092","volume":"48","author":"IA Akkouh","year":"2022","unstructured":"Akkouh IA, Hribkova H, Grabiec M, Budinska E, Szabo A, Kasparek T, et al. Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response. Schizophr Bull. 2022;48:190\u20138.","journal-title":"Schizophr Bull"},{"key":"2861_CR178","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/glia.24131","volume":"70","author":"M Koskuvi","year":"2022","unstructured":"Koskuvi M, Lehtonen \u0160, Trontti K, Keuters M, Wu Y-C, Koivisto H, et al. Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia. Glia. 2022;70:650\u201360.","journal-title":"Glia"},{"key":"2861_CR179","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00210-020-01929-8","volume":"393","author":"S-S Hsu","year":"2020","unstructured":"Hsu S-S, Liang W-Z. Ca2+ signaling as a mechanism of haloperidol-induced cytotoxicity in human astrocytes and assessing the protective role of a Ca2+ chelator. Naunyn-Schmiedeberg\u2019s. Arch Pharmacol. 2020;393:2117\u201327.","journal-title":"Arch Pharmacol"},{"key":"2861_CR180","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1177\/15353702231222027","volume":"248","author":"I Schmitz","year":"2023","unstructured":"Schmitz I, da Silva A, Bobermin LD, Gon\u00e7alves C-A, Steiner J, Quincozes-Santos A. The Janus face of antipsychotics in glial cells: Focus on glioprotection. Exp Biol Med. 2023;248:2120\u201330.","journal-title":"Exp Biol Med"},{"key":"2861_CR181","doi-asserted-by":"crossref","unstructured":"Zhang X, Wolfinger A, Wu X, Alnafisah R, Imami A, Hamoud A-R et al. Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets. Cells. 2022;11:3315.","DOI":"10.3390\/cells11203315"},{"key":"2861_CR182","volume":"11","author":"P Jeon","year":"2021","unstructured":"Jeon P, Mackinley M, Th\u00e9berge J, Palaniyappan L. The trajectory of putative astroglial dysfunction in first episode schizophrenia: a longitudinal 7-Tesla MRS study. Sci Rep. 2021;11:22333.","journal-title":"Sci Rep"},{"key":"2861_CR183","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/mp.2013.182","volume":"19","author":"A Lima","year":"2014","unstructured":"Lima A, Sardinha VM, Oliveira AF, Reis M, Mota C, Silva MA, et al. Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats. Mol Psychiatry. 2014;19:834\u201341.","journal-title":"Mol Psychiatry"},{"key":"2861_CR184","doi-asserted-by":"crossref","unstructured":"Vivi E, Di Benedetto B. Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders. Mol Psychiatry. 2024;29:2821\u201333.","DOI":"10.1038\/s41380-024-02534-4"},{"key":"2861_CR185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00406-010-0166-2","volume":"261","author":"D Martins-de-Souza","year":"2011","unstructured":"Martins-de-Souza D, Lebar M, Turck CW. Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. Eur Arch psychiatry Clin Neurosci. 2011;261:217\u201328.","journal-title":"Eur Arch psychiatry Clin Neurosci"},{"key":"2861_CR186","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuint.2010.02.013","volume":"57","author":"S Ben Achour","year":"2010","unstructured":"Ben Achour S, Pascual O. Glia: the many ways to modulate synaptic plasticity. Neurochemistry Int. 2010;57:440\u20135.","journal-title":"Neurochemistry Int"},{"key":"2861_CR187","first-page":"32","volume":"31","author":"Z Shao","year":"2006","unstructured":"Shao Z, Dyck LE, Wang H, Li X-M. Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. J Psychiatry Neurosci. 2006;31:32\u20137.","journal-title":"J Psychiatry Neurosci"},{"key":"2861_CR188","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ceb.2011.09.002","volume":"23","author":"M Banasr","year":"2011","unstructured":"Banasr M, Dwyer JM, Duman RS. Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin cell Biol. 2011;23:730\u20137.","journal-title":"Curr Opin cell Biol"},{"key":"2861_CR189","first-page":"701","volume":"11","author":"Y-M Mao","year":"2015","unstructured":"Mao Y-M, Zhang M-D. Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat. 2015;11:701\u201313.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2861_CR190","doi-asserted-by":"crossref","unstructured":"Albert K, Niskanen J, K\u00e4lv\u00e4l\u00e4 S, Lehtonen \u0160. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. Int J Mol Sci. 2021;22:4334.","DOI":"10.3390\/ijms22094334"},{"key":"2861_CR191","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S, et al. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease. N Engl J Med. 2020;382:1926\u201332.","journal-title":"N Engl J Med"},{"key":"2861_CR192","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s40265-013-0146-8","volume":"73","author":"EJ M\u00fcnzel","year":"2013","unstructured":"M\u00fcnzel EJ, Williams A. Promoting remyelination in multiple sclerosis-recent advances. Drugs. 2013;73:2017\u201329.","journal-title":"Drugs"},{"key":"2861_CR193","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","volume":"65","author":"S Mi","year":"2009","unstructured":"Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol. 2009;65:304\u201315.","journal-title":"Ann Neurol"},{"key":"2861_CR194","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2003.09.002","volume":"15","author":"CL Howe","year":"2004","unstructured":"Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004;15:120\u201331.","journal-title":"Neurobiol Dis"},{"key":"2861_CR195","doi-asserted-by":"crossref","first-page":"19162","DOI":"10.1073\/pnas.0902834106","volume":"106","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA. 2009;106:19162\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2861_CR196","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SPJ Fancy","year":"2009","unstructured":"Fancy SPJ, Baranzini SE, Zhao C, Yuk D-I, Irvine K-A, Kaing S, et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009;23:1571\u201385.","journal-title":"Genes Dev"},{"key":"2861_CR197","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1471-4159.2006.03896.x","volume":"98","author":"K Loulier","year":"2006","unstructured":"Loulier K, Ruat M, Traiffort E. Increase of proliferating oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral ventricle. J Neurochem. 2006;98:530\u201342.","journal-title":"J Neurochem"},{"key":"2861_CR198","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","volume":"14","author":"JK Huang","year":"2011","unstructured":"Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci. 2011;14:45\u201353.","journal-title":"Nat Neurosci"},{"key":"2861_CR199","doi-asserted-by":"crossref","unstructured":"Rosa V de, Secondo A, Pannaccione A, Ciccone R, Formisano L, et al. D-Aspartate treatment attenuates myelin damage and stimulates myelin repair. EMBO Mol Med. 2019;11:e9278.","DOI":"10.15252\/emmm.201809278"},{"key":"2861_CR200","doi-asserted-by":"crossref","unstructured":"Messina A, Concerto C, Rodolico A, Petralia A, Caraci F, Signorelli MS. Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs-A Review. Brain Sci. 2023;13:957.","DOI":"10.3390\/brainsci13060957"},{"key":"2861_CR201","doi-asserted-by":"crossref","unstructured":"Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC et al. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2023;24:5250.","DOI":"10.3390\/ijms24065250"},{"key":"2861_CR202","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2013.09.011","volume":"151","author":"Y Seki","year":"2013","unstructured":"Seki Y, Kato TA, Monji A, Mizoguchi Y, Horikawa H, Sato-Kasai M, et al. Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-\u03b3-stimulated microglia in co-culture model. Schizophrenia Res. 2013;151:20\u20138.","journal-title":"Schizophrenia Res"},{"key":"2861_CR203","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jnr.22824","volume":"90","author":"T Schmitz","year":"2012","unstructured":"Schmitz T, Endesfelder S, Chew L-J, Zaak I, B\u00fchrer C. Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation. J Neurosci Res. 2012;90:933\u201344.","journal-title":"J Neurosci Res."},{"key":"2861_CR204","volume":"2","author":"PVS Magalh\u00e3es","year":"2016","unstructured":"Magalh\u00e3es PVS, Dean O, Andreazza AC, Berk M, Kapczinski F. Antioxidant treatments for schizophrenia. Cochrane Database Syst Rev. 2016;2:CD008919.","journal-title":"Cochrane Database Syst Rev"},{"key":"2861_CR205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","volume":"54","author":"CO Yolland","year":"2020","unstructured":"Yolland CO, Hanratty D, Neill E, Rossell SL, Berk M, Dean OM, et al. Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia. Aust NZ J Psychiatry. 2020;54:453\u201366.","journal-title":"Aust NZ J Psychiatry"},{"key":"2861_CR206","first-page":"214","volume":"3","author":"TW Sedlak","year":"2018","unstructured":"Sedlak TW, Nucifora LG, Koga M, Shaffer LS, Higgs C, Tanaka T, et al. Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study. Mol Neuropsychiatry. 2018;3:214\u201322.","journal-title":"Mol Neuropsychiatry"},{"key":"2861_CR207","doi-asserted-by":"crossref","first-page":"62","DOI":"10.9758\/cpn.2015.13.1.62","volume":"13","author":"A Shiina","year":"2015","unstructured":"Shiina A, Kanahara N, Sasaki T, Oda Y, Hashimoto T, Hasegawa T, et al. An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia. Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol. 2015;13:62\u20137.","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"2861_CR208","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361\u20138.","journal-title":"Biol Psychiatry"},{"key":"2861_CR209","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1007\/s12035-021-02574-9","volume":"58","author":"A Quincozes-Santos","year":"2021","unstructured":"Quincozes-Santos A, Santos CL, de Souza Almeida RR, da Silva A, Thomaz NK, et al. Gliotoxicity and Glioprotection: the Dual Role of Glial Cells. Mol Neurobiol. 2021;58:6577\u201392.","journal-title":"Mol Neurobiol"},{"key":"2861_CR210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ijnp\/pyaa006","volume":"23","author":"A Samaei","year":"2020","unstructured":"Samaei A, Moradi K, Bagheri S, Ashraf-Ganjouei A, Alikhani R, Mousavi SB, et al. Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial. Int J Neuropsychopharmacol. 2020;23:775\u201382.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2861_CR211","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/dneu.22590","volume":"78","author":"L Tomlinson","year":"2018","unstructured":"Tomlinson L, Huang PH, Colognato H. Prefrontal cortex NG2 glia undergo a developmental switch in their responsiveness to exercise. Developmental Neurobiol. 2018;78:687\u2013700.","journal-title":"Developmental Neurobiol"},{"key":"2861_CR212","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41587-023-01798-5","volume":"42","author":"R Vieira","year":"2024","unstructured":"Vieira R, Mariani JN, Huynh NPT, Stephensen HJT, Solly R, Tate A, et al. Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain. Nat Biotechnol. 2024;42:719\u201330.","journal-title":"Nat Biotechnol"},{"key":"2861_CR213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362:329\u201344.","journal-title":"N Engl J Med"},{"key":"2861_CR214","volume":"144","author":"T-I Kam","year":"2020","unstructured":"Kam T-I, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol Dis. 2020;144:105028.","journal-title":"Neurobiol Dis"},{"key":"2861_CR215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0025-7125(02)00011-1","volume":"86","author":"A Kertesz","year":"2002","unstructured":"Kertesz A, Munoz DG. Frontotemporal dementia. Med Clin North Am. 2002;86:501\u201318.","journal-title":"Med Clin North Am"},{"key":"2861_CR216","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","volume":"57","author":"The Lund and Manchester Groups.","year":"1994","unstructured":"The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2861_CR217","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A. The Alzheimer\u2019s Disease Clinical Spectrum: Diagnosis and Management. Med Clin North Am. 2019;103:263\u201393.","journal-title":"Med Clin North Am"},{"key":"2861_CR218","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"2861_CR219","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386:1672\u201382.","journal-title":"Lancet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02861-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:42:50Z","timestamp":1739871770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02861-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":219,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02861-6","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}